Predictors of unsuccessful tuberculosis treatment outcomes in children from a prospective cohort study in Pakistan

Meredith B Brooks1, Amyn Malik2,3,4, Salman Khan2

  • 1Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Insights

High treatment success rates were observed in children with drug-susceptible tuberculosis (TB). Fever and abdominal findings increased the risk of poor outcomes, while rural facility treatment decreased it.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) causes approximately 239,000 child deaths annually despite effective treatments.
  • Limited research exists on predictors of poor treatment outcomes in pediatric TB cases.

Purpose of the Study:

  • To identify predictors of unsuccessful treatment outcomes in children with drug-susceptible TB.
  • To evaluate individual, clinical, and facility-level factors associated with TB treatment success in children.

Main Methods:

  • A prospective cohort study was conducted in Pakistan (2014-2016) involving children diagnosed with TB via an intensified case-finding intervention.
  • TB diagnosis was confirmed bacteriologically or clinically.
  • A multi-level modified Poisson regression model was used to assess predictors of unsuccessful treatment outcomes, accounting for facility-level clustering.

Main Results:

  • Of 1404 children treated for TB, 94.2% had successful outcomes. Unsuccessful outcomes (4.8%) included death (1.0%), treatment failure (1.4%), and loss to follow-up (2.4%).
  • Children presenting with fever (RR=2.56) or abdominal findings suggestive of TB (RR=2.34) had increased risk of unsuccessful outcomes.
  • Initiating treatment at a rural facility was associated with a decreased risk of unsuccessful outcomes (RR=0.05).

Conclusions:

  • Over 94% of children achieved successful TB treatment outcomes.
  • Fever, abdominal findings suggestive of TB, and treatment facility location are significant predictors of pediatric TB treatment outcomes.
  • Close monitoring and support are crucial for children with fever and abdominal TB symptoms to ensure treatment completion.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...